NeurOp, Inc. is a biotechnology company developing new medicines for central nervous system disorders including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Alzheimer’s and Parkinson’s diseases.

Latest News

NeurOp Announces Strategic Collaboration with Johnson & Johnson Innovation to Study Role of NMDA Receptors.


Our Science

Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.

About Us

Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.